Midwest Symposium on Oligonucleotide Therapeutics
2022-08-06 - 2022-08-08 | Hilton Indianapolis Hotel & Suites, 120 W Market St, Indianapolis, IN, 46204, United States
The Midwest Symposium on Oligonucleotide Therapeutics is a grassroots meeting in Indianapolis supported by an Oligonucleotide Therapeutics Society (OTS) Local Delivery Grant. This regional meeting is hosted by OTS members, Rebecca Miles and Leonora Abdullahu with the objective to share knowledge among oligonucleotide therapeutic researchers. We hope to serve the student community in the Midwest to create an affordable and high value scientific meeting that will cultivate professional development and networking.

Genome Engineering: CRISPR Frontiers
2022-08-24 - 2022-09-25 | Cold Spring Harbor, One Bungtown Road, Cold Spring Harbor, 11724, United States
The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR-Cas and related bacterial defense systems.
Organizers: Jennifer Doudna, PhD, David Liu, PhD

2022 DOE Joint Genome Institute (JGI) Genomics of Energy & Environment Meeting
2022-08-28 - 2022-08-31 | Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA, 94720, United States
All are welcome to register and join the 2022 DOE Joint Genome Institute (JGI) Genomics of Energy & Environment Meeting, which coincides with our 25th Anniversary. The JGI convenes this annual gathering of leaders from diverse disciplines to highlight how they are addressing the world’s most pressing energy and environmental challenges. Many of these presenters have been supported by the research infrastructure – DNA sequencing, synthesis, metabolomics, data analysis, and new technology developments – that the JGI offers through its User Programs on a competitive, peer-reviewed basis to the worldwide scientific community. This year’s Meeting, to be held August 29 – 31, will be a hybrid event – in person at Lawrence Berkeley National Laboratory (Berkeley Lab) – and virtually through the Social27 platform.

Advanced Therapies Europe
2022-08-30 - 2022-09-01 | Royal Lancaster London, Lancaster Terrace, London, W2 2TY, United Kingdom
This year we are bringing the event back to be more commercially and strategically focused, where in an intimate setting attendees will have the opportunity to connect with the full cell & gene community, enabling a 360-degree view on the current landscape.
It’s the destination for those wanting to debate the challenges, explore the opportunities, and discover the latest innovations, all within Europe and the UK.
In a bespoke setting, attendees will have access to the complete European advanced therapies landscape from macro to micro.
It’s the only event to offer companies a credible platform to position their company and solutions as leading providers in the advanced therapies technology and services space, including being able to place their brand directly under the nose of key decision makers from across Europe and the UK.
Hosted in London the event is positioned front and center of all the action within the European advanced therapies landscape.

2022 RARE Patient Advocacy Summit
2022-09-11 - 2022-09-14 | Town & Country Hotel, 500 Hotel Circle North, San Diego, CA, 92108, United States
Each year, Global Genes convenes one of the world’s largest gatherings of rare disease patients, caregivers, advocates, healthcare professionals, researchers, partners, and allies at the RARE Patient Advocacy Summit.
This year we’re celebrating being back together again, and have opportunities for you to join us in person or online for two days of connection opportunities, educational sessions, fun, and the RARE Champions of Hope Awards Ceremony and Dinner!
Summit sessions provide attendees with insights about the latest in rare disease innovations, best practices for advocating on an individual and organizational level, and actionable strategies to take home. This year, the Summit will be a hybrid event so all can attend – in person at the Town & Country Hotel in San Diego, California and live streamed online in our virtual event platform.

Cell & Gene Therapy USA 2022
2022-09-19 - 2022-09-21 | VIRTUAL
With over 20 CGTs projected to be approved by 2025, it’s clear that there are huge commercial and medical opportunities for precision medicine. But despite this unprecedented growth, unstable infrastructure, lack of standardization and novel scientific nuance means that there is still no industry blueprint for successful commercialization.
To realize this potential, precision medicine trailblazers must share lessons of launch success and overcome pain points to allow pharma to reinforce frameworks across manufacturing, market access and reimbursement to build infallible launch strategies across the board. Commercialization networks must go even further, transforming our healthcare system to guarantee scalable and sustainable growth.
Don’t get left behind.
Join us at Reuters Events: Cell and Gene Therapy USA where we have leaders from industry front runners to share their successes and pitfalls. With 30+ speakers, 5 case-studies and over 1500+ fellow CGT attendees – we will pioneer a new gold standard for commercialization, readying the world for CGT as a frontline treatment.

ISSCR/ASGCT 2022 Madison International Symposium
2022-09-20 - 2022-09-23 | Monona Terrace Community and Convention Center, 1 John Nolen Dr, Madison, WI, 53703, United States
The International Society for Stem Cell Research (ISSCR) and the American Society for Gene and Cell Therapy (ASGCT) are partnering to host an exciting program on the latest advancements in regenerative medicine at the intersection of genetic and cellular technologies.
The marriage of genomic and cellular advances holds tremendous potential for regenerative medicine. Recent discoveries in stem cell biology are being combined with powerful new gene-editing technologies to bring about potentially transformative new therapies for diseases affecting a wide range of tissue and organ systems. This three day meeting will highlight groundbreaking work developing therapies for diseases of the nervous, hematopoietic, and muscle systems, diabetes, metabolic diseases, and cancer, and feature forward-looking new technologies shaping the future of the field.
Join us on 21 – 23 September 2022 when world-renowned scientists developing gene and cell therapies will converge at the Monona Terrace Community and Convention Center in Madison, WI, a city recognized for its seminal contributions to human stem cell research. Scientists, researchers, and industry leaders will present new discoveries at the leading edge of regenerative medicine.

The State of Biotech
2022-09-20 - 2022-09-22 | VIRTUAL
This is a fascinating, exciting, and perplexing time for biotechnology. The industry delivered RNA vaccines to save countless lives during the pandemic and has created impressive early clinical results using CRISPR gene editing to treat patients with deadly genetic diseases. And yet the sector has been tarnished with safety concerns, drug failures, and lay-offs.

For more than 40 years, Genetic Engineering & Biotechnology News (GEN) has been covering the world of biotechnology. This September, we will cover it as never before – in a must-attend virtual event hosted by GEN Edge, the premium subscription news service of GEN.

THE STATE OF BIOTECH is an essential virtual summit (spanning two half days) featuring leaders from industry, academia, and finance discussing the latest critical breakthroughs, trends, and challenges in the biotech industry. The event will feature presentations and conversations with a trove of biotech leaders and entrepreneurs, brilliant scientists and innovators, and renowned analysts and commentators.

Human Gene Therapy Conference
2022-09-25 - 2022-09-28 | Melbourne Convention and Exhibition Centre (MCEC), 1 Convention Centre Pl, South Wharf, Victoria, 3006, Australia
Gene Forum takes the honour to invite you to the International Human Gene Conference which will be held on September 26-28, 2022 at Melbourne Australia.
Over the past few years, Gene therapy has become a regular talk for the scientists and researchers from academia and industry all over the globe. Gene therapy is very huge and more team’s diverse research is needed to find the effective treatments and best possible ways to manage the rare diseases. With a great substantial research on genetics happening in this part of the world, therefore it has developed into a forum to discuss important challenges in this field.
The aim of the conference is to bring together all the key stakeholders interested in genetics and gene therapy to share and discuss advances and developments in these fields. Therefore we aimed at assisting academicians, business executives, researchers, scientists, manufacturers, gene therapy companies, communities, and agencies to keep on new developments in their specific fields and to join forces in finding alternative solutions.
It’s a unique way to approach and encourage a dialogue between speakers and delegates through its well-planned agenda with the series of talks, poster presentations, panel discussions and networking events that will keep participants engaged in learning. This will help rising scientific queries and provide solutions for a smarter and more advanced future.
We are stepping forward to create a platform to bring all the researchers from around the world and the research community to collaborate with the industries to focus on their efforts. The industry partners and attending experts will also provide a fantastic networking experience.

World Molecular Imaging Congress 2022
2022-09-27 - 2022-10-01 | Miami Beach Convention Center, 1901 Convention Center Drive, Miami, FL, 33139, United States
The World Molecular Imaging Congress brings together people from across the globe who represent the entire spectrum of Molecular Imaging. These individuals gather at WMIC to exchange ideas and foster innovation. The scientific and educational sessions are replete with leaders in the field and young scientists alike, each of whom has made significant contributions to our understanding of biology, advanced technology innovation, and/or evaluated new developments in the clinic. These sessions are complemented by thousands of abstracts that detail advances and highlight the latest developments in Molecular Imaging. Our industry exhibitors and sponsors showcase their innovations in the exhibition hall and lecture hall, detailing advances that will refine your animal models, accelerate your research, and improve clinical care. Each WMIC session is packed with innovative ideas and cutting-edge research. Molecular Imaging is a window into biology that enables discovery. We use these windows to investigate new biology and increase understanding, and the better we understand biological processes of living systems, with all of the contextual influences intact, the more effective our therapies will be in the clinic. Molecular Imaging lies at the heart of precision medicine. WMIC is the event that showcases all of the innovations in Molecular Imaging and shows the utility of novel imaging strategies in clinical investigation and the study of disease. Molecular Imaging as a field lies at the nexus of innovation in chemistry, hardware development, software innovation, biology, and medicine, and the WMIC is where you will hear about the most exciting highlights and the most in-depth evaluation. You will not want to miss WMIC 2022 in Miami!

18th Annual Meeting of the Oligonucleotide Therapeutics Society
2022-10-01 - 2022-10-05 | Hilton Phoenix Resort at the Peak, 7677 N 16th St, Phoenix, AZ, 85020, United States
The Oligonucleotide Therapeutics Society (OTS) Annual Meeting is a forum for the realization of the Society’s mission and goals, to foster academic and industry-based research and development of oligonucleotide therapeutics. Leaders in the field from across the globe alongside students will present on an array of topics, including chemistry, AI/machine learning, genome & RNA editing, and preclinical and clinical research.
The Annual Meeting is open to anyone interested or involved in oligonucleotide therapeutics.

2022 VEGA Symposium
2022-10-05 - 2022-10-07 | Lawrence Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA, 94720, United States
The VEGA 2022 symposium aims to bring together a “viral ecogenomics” community to foster discussion on how to best capture and characterize uncultivated viruses, understand the role of viruses in natural ecosystems, and functionally explore viral genetic diversity toward innovative biotechnological and industrial applications. This 2022 edition will focus in particular on experimental innovations, computational advances, and other technological developments that will enable researchers to functionally characterize novel viral diversity and investigate virus-virus and virus-host interactions in nature. The symposium will also include organized discussion sessions to gather input from the community on the most pressing challenges faced by researchers in the viral ecogenomics fields.
Participants will notably be invited to open discussions designed to shape the future design of IMG/VR (the database of uncultivated viral genomes) to maximize its usefulness for the different actors in the field (i.e. gene-centric experimental approaches, ecosystem models, host-based evolutionary analysis, etc), as well as frame a potential viral-focused calls for projects at the JGI.

Drug Repurposing for Rare Diseases 2022
2022-10-09 - 2022-10-10 | America Square Conference Centre, 17, One Crosswall, America Square, London, EC3N 2LB, United Kingdom
Our annual conference highlights the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments.
The drug repurposing field has shifted after stepping into the limelight during the COVID-19 pandemic. The world is beginning to care about drug repurposing and is recognizing the opportunities to repurpose a drug to treat an often rare and neglected condition.
Repurposing schemes, projects and ideas are all in place to accelerate access to desperately needed medicines – the answers have been right under our noses all along!

29th Congress of the European Society of Gene and Cell Therapy
2022-10-10 - 2022-10-14 | Edinburgh International Conference Centre, The Exchange, 150 Morrison St, Edinburgh, United Kingdom

2022 Cell & Gene Meeting on the Mesa
2022-10-10 - 2022-10-13 | Carlsbad, CA
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 3,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Cardiovascular Disease Model Satellite 2022, 20th International SHR Symposium & 58th Japanese SHR Meeting
2022-10-15 - 2022-10-17 | Shirankaikan Annex, 11-1 Yoshidaushinomiyacho,, Kyoto, Sakyo Ward, 606-8302, Japan
Cardiovascular disease model research has seen remarkable advances in the last decade. The technology is staggering, the magnitude of human studies is extraordinary, the sophistication of animal models is outstanding, and the revelations regarding the insights into the genomics and other omics are absolutely fascinating. Yet the future prospects are even more exciting. These will be core elements of the Cardiovascular Disease Model Satellite 2022, with the main theme
“Innovative science of hypertension-related disease model towards precision medicine and prevention” to envision the future, building on today’s achievements.
Cardiovascular Disease Model Satellite 2022 is an official investigator-led satellite to the
International Society of Hypertension Meeting in October 2022 and we are delighted that it will also incorporate the 20th International SHR Symposium and the 58th Japanese SHR Meeting. We should like you to be part of this stimulating meeting. The quality of our Committees and International Advisory Board will ensure that the research presented is at the forefront of the field. This will include the latest in genomics and other omics discovery, control and integration of gene expression, biomarkers, systems biology, pharmacogenomics, epigenetics and functional validation. The Satellite will span 1.5 days and will be held on Sunday 16 and Monday 17 October 2022. Although the Satellite was scheduled to be held in a hybrid format (face-to-face and virtual), I announce with great regret that we have decided to hold the meeting in a semi-hybrid format. That is, except for the speakers who can come to deliver their presentation at the venue located within the Kyoto University, the other speakers and the audience will participate in the meeting online. As an Investigator-Led Satellite, we are keeping costs to minimum and you will find details regarding Abstract Submission, Registration and related matters on this website.
We look forward to your participation in a memorable meeting and contribution to future of Cardiovascular Disease Model Research.

NYSCF Conference
2022-10-17 - 2022-10-19 | The Rockefeller University, 1230 York Ave, New York, NY, 10065, United States
The NYSCF Conference is the premier translational stem cell research conference. Held annually for the past 16 years, it has brought together world-leading experts from various disciplines across biomedicine and biotechnology to present the latest cutting-edge stem cell science.

Tri-Omics Summit Europe
2022-10-17 - 2022-10-20
Extraordinary times call for extraordinary events! Therefore, it’s our pleasure to invite you to the Tri-Omics Summit, coming to London in October 2022 as a one-stop-shop for multi-disciplinary teams to come together to address the challenges of “omics” data analysis and effectively deliver precision medicine.
Join us from 18th-20th October as we explore the realms of multi-omics, single cell & spatial analysis and cancer genomics from discovery, through translation and into meaningful clinical outcomes for patients.
Driven by our social mission, we are pleased to offer free tickets to everybody employed exclusively by a research institution, hospital, clinic or a pharma company with an existing drug pipeline.
You can expect to hear from experts in the fields of multi-omics, single cell & spatial omics and cancer genomics.

ASHG 2022 Annual Meeting
2022-10-25 - 2022-10-29 | Los Angeles Convention Center, 1201 S Figueroa St, Los Angeles, CA, 90015, United States
We are excited to welcome you back in-person to Los Angeles for ASHG’s annual meeting, taking place this October 25-29. Attendees can look forward to reconnecting with peers, engaging in discussions on research findings and sessions, all while enjoying the beautiful attractions and backdrop LA has to offer for this long-awaited reunion.

Process Intensification: Improving the Process Status Quo
2022-10-27 10:00 - 12:00 (America/Chicago) | VIRTUAL
The goal is to make more products faster and more efficiently, without sacrificing quality. Before implementing change, you need to answer several core questions, including: How can I intensify an established process with minimal risk? Why should I change a working, validated process? What are the appropriate technology options and what metrics should be considered to justify their investment?
Our speakers provide insight on their experiences, decision-making processes and outcomes.

Cell Symposia: Hallmarks of Cancer
2022-10-29 - 2022-11-01 | Paradise Point Resort & Spa, 1404 Vacation Rd, San Diego, CA, 92109, United States
Hallmarks of Cancer Cell Symposium is one of the most popular and longest-lasting conference series of Cell Press, and has been successfully held in the United States, Europe, and China previously. High-quality talks from highly respected cancer researchers and oncologists will strengthen and extend our understanding of cancer biology and accelerate the translation of the cutting-edge knowledge into more effective therapies. As a tradition, our “Meet the Speakers” dinner provides an additional great platform to communicate with leaders in the community in an interactive, productive, and relaxed environment. The year of 2022 also marks the 20th anniversary of Cancer Cell, and the meeting attendees are all invited to join our celebration of 20 years of serving this great community. After the disruption in scientific communication and social isolation imposed by lockdowns and travel restrictions, we are excited to meet you and talk about science in person. Come and join us in San Diego this fall.

5th International Conference on CRISPR Technologies
2022-10-30 - 2022-11-02 | UC Berkeley, Berkeley, CA, United States
CRISPR 2022 brings together investigators focused on enzymes and technologies, predominantly CRISPR-based systems, but also other promising systems and approaches, to discuss advances in the field and ways to harness genome engineering for beneficial purposes. Topics range from fundamental biology to translational and applied applications and include studies across the diversity of life. Importantly, speakers and participants represent both academic and commercial interests.

14th Annual Protein & Antibody Engineering Summit
2022-11-13 - 2022-11-16 | InterContinental Barcelona, Av. de Rius i Taulet, 1-3, 08004, Barcelona, 08004, Spain
Network with 1,200 colleagues at PEGS Europe, the largest protein & antibody engineering event in Europe, which has been described as “the best biologics technology meeting in Europe.” Last year, nearly 900 delegates from 35 countries, including 78% from pharma and biotech organizations, convened in beautiful Barcelona and online to discuss the latest advances in protein and antibody engineering.

ISSCR 2022 Boston International Symposium
2022-11-16 - 2022-11-19 | Boston Marriott Cambridge, 50 Broadway, Cambridge, MA, 02142, United States
Join us for the ISSCR 2022 Boston International Symposium on Cell Manufacturing and Commercialization “Translating Pluripotent Stem Cell Discoveries to the Clinic: Preclinical, Manufacturing, and Regulatory Strategies for Success,” which will take place at the Boston Marriott Cambridge Boston, MA from 17-19 November 2022.
The meeting will bring together international academic and commercial scientists with expertise in the preclinical, clinical, and regulatory phases to discuss the critical processes and strategies in the successful development of PSC-derived therapies. Sessions will cover some of the latest thinking and approaches for selecting the cell line, characterizing the product and manufacturing considerations, managing the immune system, and working with regulators throughout the process. We hope you can join us in one of the world’s hubs of biotechnology.

Cell Bio 2022
2022-12-02 - 2022-12-07 | Walter E. Washington Convention Center, 801 Mount Vernon Place NW, Washington DC, DC, 20001, United States
After two years, Cell Bio 2022 will return as an in-person meeting December 3-7, 2022, in Washington, DC. We are excited to make it possible for colleagues to reconnect face-to-face, while keeping health and safety paramount. We understand flexibility is also important. In addition to our in-person meeting, limited content will be available on-demand for purchase after the meeting so that all scientists can access the cutting-edge cell biology research that was presented during the in-person meeting.

Advances in Therapeutic Applications of Stem Cells
2022-12-07 - 2022-12-10 | Cedars-Sinai Medical Center, 8700 Beverly Blvd #2900A, Los Angeles, CA, 90048, United States
Stem cells are moving toward the clinic as cellular therapeutics in several indications and are being tested in clinical trials in others. They are also employed to advantage in the discovery of novel therapeutics in several modalities, including physiologically relevant toxicity and drug screening platforms, and lend themselves to other treatment modalities, including gene therapy, and personalized precision medicine.
The goal of this Cell Symposium is to bring together clinicians, academic researchers, and industry and regulatory stakeholders to discuss advances in the field and to champion new ideas to overcome the current challenges across the clinical and translational spectrum of stem–cell-based research and therapy.

International Conference on CRISPR and Gene Editing
2022-12-14 - 2022-12-16 | VIRTUAL
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on CRISPR and Gene Editing aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of CRISPR and Gene Editing. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of CRISPR and Gene Editing.

Cell Therapy Manufacturing Strategies: Autologous vs. Allogeneic
2022-12-15 10:00 - 12:00 | VIRTUAL
There have been tremendous advancements and breakthroughs in cell therapy treatments. Autologous treatments are extremely effective personalized therapies, but have significant medical, cost and commercialization limitations. Allogeneic treatments provide us with an opportunity to expand and extend access to personalized therapies to patients in need, but face efficacy, safety, and process hurdles.
While related, the differences are stark, forcing your company to make unique and critical process and business decisions to ensure your company implements the best technologies to execute the most effective autologous and/or allogeneic cell therapy manufacturing strategy.

Pre-Filled Syringes and Injectable Drug Devices Europe
2023-01-09 - 2023-01-12 | Copthorne Tara Hotel London Kensington, Scarsdale Pl, London, W8 5SY, United Kingdom
SAE Media Group’s 15th Annual Pre-Filled Syringes and Injectable Drug Devices Conference will be bigger than ever, with a pre-conference focus day exploring the advances in PFS design for enhanced drug delivery proceeded by a two-day main conference comprising of morning keynote plenaries and parallel afternoon topic streams as detailed below:
• Novel Drug Products and Large Volume Delivery
• Sustainability for Injectable Delivery Devices
• Primary Packaging Development
• Connected Drug Delivery Devices

PepTalk: The Protein Science and Production Week
2023-01-15 - 2023-01-20 | Hilton San Diego Bayfront, 1 Park Blvd, San Diego, CA, 92101, United States
PepTalk connects protein science researchers from around the globe to share case studies, unpublished data, breakthroughs, and solutions that support and enhance biotherapeutics R&D.

This year’s event will feature world-renowned speakers, cutting-edge technologies, and engaging networking events. Programming includes in-depth coverage of antibody discovery, protein engineering, bispecific antibodies, emerging immunotherapies, protein aggregation, machine learning, cell and gene therapy, protein expression, purification and production.
